Browsing Tag
EHA2024
1 post
Agios Pharmaceuticals’ mitapivat shows significant promise in Phase 3 ENERGIZE study
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a pioneer in cellular metabolism and pyruvate kinase (PK) activation therapies, unveiled detailed…